0001209191-22-049253.txt : 20220909 0001209191-22-049253.hdr.sgml : 20220909 20220909071645 ACCESSION NUMBER: 0001209191-22-049253 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220901 FILED AS OF DATE: 20220909 DATE AS OF CHANGE: 20220909 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SMITH J. JEFFERSON CENTRAL INDEX KEY: 0001770169 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38841 FILM NUMBER: 221235040 MAIL ADDRESS: STREET 1: C/O PRECISION BIOSCIENCES, INC. STREET 2: 302 EAST PETTIGREW STREET, SUITE A-100 CITY: DURHAM STATE: NC ZIP: 27701 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PRECISION BIOSCIENCES INC CENTRAL INDEX KEY: 0001357874 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 302 EAST PETTIGREW STREET STREET 2: SUITE A-100 CITY: DURHAM STATE: NC ZIP: 27701 BUSINESS PHONE: 919-314-5512 MAIL ADDRESS: STREET 1: 302 EAST PETTIGREW STREET STREET 2: SUITE A-100 CITY: DURHAM STATE: NC ZIP: 27701 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2022-09-01 0 0001357874 PRECISION BIOSCIENCES INC DTIL 0001770169 SMITH J. JEFFERSON C/O PRECISION BIOSCIENCES, INC. 302 E. PETTIGREW STREET, SUITE A-100 DURHAM NC 27701 0 1 0 0 Chief Research Officer Common Stock 1902474 D Common Stock 237959 I By Charitable Remainder Unitrust Employee Stock Option (Right to Buy) 1.18 2027-03-23 Common Stock 23422 D Employee Stock Option (Right to Buy) 11.98 2028-10-11 Common Stock 46845 D Employee Stock Option (Right to Buy) 5.83 2030-08-20 Common Stock 35786 D Employee Stock Option (Right to Buy) 11.34 2031-06-06 Common Stock 25118 D Restricted Stock Units Common Stock 9744 D Employee Stock Option (Right to Buy) 4.08 2032-03-02 Common Stock 74197 D Restricted Stock Units Common Stock 46720 D Stock options are fully vested as of the date of this report. The option vested as to 25% of the underlying shares on September 28, 2019 and thereafter in twelve substantially equal installments at the end of each three-month period over the 36 months following such date, subject to the Reporting Person's continued service to the Company through the applicable vesting dates. The option vested as to 25% of the underlying shares on April 1, 2021 and thereafter in twelve substantially equal installments at the end of each three-month period over the 36 months following such date, subject to the Reporting Person's continued service to the Company through the applicable vesting dates. The option vested as to 25% of the underlying shares on June 7, 2022 and thereafter in twelve substantially equal installments at the end of each three-month period over the 36 months following such date, subject to the Reporting Person's continued service to the Company through the applicable vesting dates. The restricted stock units ("RSUs") vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Company through the applicable vesting dates. The Reporting Person was granted RSUs, which each represents a contingent right to receive one share of the Company's Common Stock. The option vests as to 25% of the underlying shares on March 3, 2023 and thereafter in twelve substantially equal installments at the end of each three-month period over the 36 months following such date, subject to the Reporting Person's continued service to the Company through the applicable vesting dates. The RSUs vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Company through the applicable vesting dates. Exhibit List: Exhibit 24 Power of Attorney /s/ Dario Scimeca, Attorney-in-Fact for J. Jefferson Smith 2022-09-09 EX-24 2 poa.txt POA DOCUMENT POWER OF ATTORNEY J. Jefferson Smith With respect to holdings of and transactions in securities issued by Precision Biosciences, Inc. (the "Company"), the undersigned hereby constitutes and appoints the individuals named on Schedule A attached hereto and as may be amended from time to time, or any of them signing singly, with full power of substitution and resubstitution, to act as the undersigned's true and lawful attorney-in-fact to: 1. prepare, execute in the undersigned's name and on the undersigned's behalf, and submit to the United States Securities and Exchange Commission (the "SEC") a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain and/or regenerate codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act of 1934, as amended, or any rule or regulation of the SEC; 2. execute for and on behalf of the undersigned, Forms 3, 4, and 5 in accordance with Section 16 of the Securities Exchange Act of 1934, as amended, and the rules thereunder; 3. do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute any amendment or amendments thereto, and timely file such form with the SEC and any stock exchange or similar authority; and 4. take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in his or her discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution and resubstitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorneys-in-fact substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is any Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934, as amended. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 2nd day of September, 2022. /s/ J. Jefferson Smith J. Jefferson Smith Schedule A Individual Appointed as Attorney-in-Fact with Full Power of Substitution and Resubstitution Dario Scimeca Alex Kelly